CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Muller Lorenz Chief Commercial Officer | Grant or award · Restricted Stock Unit | +136,000 | 136,000 | ||
| 2026-02-02 | Oliveto Joseph President and CEO | Grant or award · Employee Stock Option (right to buy) | +679,000 | 679,000 | ||
| 2026-02-02 | Oliveto Joseph President and CEO | Grant or award · Restricted Stock Unit | +453,000 | 453,000 | ||
| 2026-01-26 | Nelson Jeffrey Edward Chief Operating Officer | Option exercise | +20,100 | 62,093 | ||
| 2026-01-26 | Nelson Jeffrey Edward Chief Operating Officer | Sale | −12,245 | $1.93 | $24K | 49,848 |
| 2026-01-26 | Nelson Jeffrey Edward Chief Operating Officer | Option exercise · Restricted Stock Units | −20,100 | 60,300 | ||
| 2026-01-26 | Bharucha David Chief Medical Officer | Option exercise | +20,100 | 125,426 | ||
| 2026-01-26 | Bharucha David Chief Medical Officer | Sale | −12,245 | $1.93 | $24K | 113,181 |
| 2026-01-26 | Bharucha David Chief Medical Officer | Option exercise · Restricted Stock Units | −20,100 | 60,300 | ||
| 2026-01-26 | Hasija Amit CFO & EVP of Corp. Development | Option exercise | +20,100 | 112,093 | ||
| 2026-01-26 | Hasija Amit CFO & EVP of Corp. Development | Sale | −12,245 | $1.93 | $24K | 99,848 |
| 2026-01-26 | Hasija Amit CFO & EVP of Corp. Development | Option exercise · Restricted Stock Units | −20,100 | 60,300 | ||
| 2026-01-26 | Muller Lorenz Chief Commercial Officer | Option exercise | +20,100 | 216,586 | ||
| 2026-01-26 | Muller Lorenz Chief Commercial Officer | Sale | −11,180 | $1.93 | $22K | 205,406 |
| 2026-01-26 | Muller Lorenz Chief Commercial Officer | Option exercise · Restricted Stock Units | −20,100 | 60,300 | ||
| 2026-01-26 | Oliveto Joseph President and CEO | Option exercise | +66,600 | 517,267 | ||
| 2026-01-26 | Oliveto Joseph President and CEO | Sale | −34,523 | $1.93 | $67K | 482,744 |
| 2026-01-26 | Oliveto Joseph President and CEO | Option exercise · Restricted Stock Units | −66,600 | 199,800 | ||
| 2026-01-08 | Oliveto Joseph President and CEO | Sale 10b5-1 | −43,000 | $2.25 | $97K | 303,721 |
| 2026-01-07 | Oliveto Joseph President and CEO | Sale 10b5-1 | −500 | $2.25 | $1K | 346,721 |
Page 2 of 9 · 163 trades